SLICC衰弱指数在系统性红斑狼疮患者中的特性及其与死亡风险的关联
基于SLICC起始队列1683例SLE患者的二次分析,构建包含48项健康缺陷的SLICC衰弱指数(SLICC-FI),评估其内容、结构与标准效度,并采用多因素Cox回归分析基线SLICC-FI与死亡风险的关联。结果显示基线SLICC-FI均值为0.17±0.08,与基线SDI弱相关(r=0.26,P<0.0001);校正年龄、性别、激素使用、种族/地区及基线SDI后,SLICC-FI每增加0.05,死亡风险增加(HR 1.59,95%CI 1.35-1.87)。
要点
- SLICC-FI包含48项健康缺陷,涵盖器官损伤、疾病活动度、合并症和功能状态。
- 基线SLICC-FI均值为0.17±0.08,与基线SDI仅弱相关(r=0.26,P<0.0001)。
- 校正混杂因素后,SLICC-FI每增加0.05,死亡风险HR为1.59(95%CI 1.35-1.87)。
核心结论
- SLICC-FI作为SLE健康测量工具具有内部效度,可能用于预测未来死亡风险。
- SLICC-FI可能有助于量化SLE患者的脆弱性,并补充现有预后评分。
研究设计与样本
- 基于SLICC起始队列的二次分析,基线定义为首次同时评估器官损伤(SDI)和健康相关生活质量(SF-36)的访视。
- 基线数据集包含1683例SLE患者,89%为女性,平均年龄35.7±13.4岁,平均病程18.8±15.7个月。
- 使用基线数据构建包含48项健康缺陷的SLICC-FI,评估内容、结构和标准效度,并采用多因素Cox回归分析其与死亡风险的关联。
主要发现
- 基线SLICC-FI均值为0.17±0.08(范围0-0.51)。
- 基线SLICC-FI与基线SDI评分弱相关(r=0.26,P<0.0001)。
- 校正年龄、性别、激素使用、种族/地区和基线SDI后,基线SLICC-FI每增加0.05与死亡风险增加相关(HR 1.59,95%CI 1.35-1.87)。
关键数值与推荐
- SLICC-FI包含48项健康缺陷,涉及器官损伤、疾病活动度、合并症和功能状态。
- 基线SLICC-FI均值0.17±0.08,范围0-0.51。
- SLICC-FI每增加0.05的死亡风险HR为1.59(95%CI 1.35-1.87),校正年龄、性别、激素使用、种族/地区和基线SDI。
临床怎么用
- SLICC-FI可作为SLE患者脆弱性的量化工具,辅助识别高死亡风险人群。
- SLICC-FI与现有预后评分联合使用可能提升风险分层能力。
局限性
- 本研究为二次分析,SLICC-FI的预测效能需在外部队列中验证。
- 基线SLICC-FI与SDI仅弱相关,提示两者捕获不同的健康维度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the properties of a frailty index (FI), constructed using data from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort, as a novel health measure in systemic lupus erythematosus (SLE). METHODS: For this secondary analysis, the baseline visit was defined as the first study visit at which both organ damage (SLICC/American College of Rheumatology Damage Index [SDI]) and health-related quality of life (Short-Form 36 [SF-36] scores) were assessed. The SLICC-FI was constructed using baseline data. The SLICC-FI comprises 48 health deficits, including items related to organ damage, disease activity, comorbidities, and functional status. Content, construct, and criterion validity of the SLICC-FI were assessed. Multivariable Cox regression was used to estimate the association between baseline SLICC-FI values and mortality risk, adjusting for demographic and clinical factors. RESULTS: In the baseline data set of 1,683 patients with SLE, 89% were female, the mean ± SD age was 35.7 ± 13.4 years, and the mean ± SD disease duration was 18.8 ± 15.7 months. At baseline, the mean ± SD SLICC-FI score was 0.17 ± 0.08 (range 0-0.51). Baseline SLICC-FI values exhibited the expected measurement properties and were weakly correlated with baseline SDI scores (r = 0.26, P < 0.0001). Higher baseline SLICC-FI values (per 0.05 increment) were associated with increased mortality risk (hazard ratio 1.59, 95% confidence interval 1.35-1.87), after adjusting for age, sex, steroid use, ethnicity/region, and baseline SDI scores. CONCLUSION: The SLICC-FI demonstrates internal validity as a health measure in SLE and might be used to predict future mortality risk. The SLICC-FI is potentially valuable for quantifying vulnerability among patients with SLE, and adds to existing prognostic scores.
引用
- Legge A, Kirkland S, Rockwood K, et al. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019. PMID: 30771242. doi:10.1002/art.40859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。